Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models.
In this study, we compared, for the first time, the release of a 432 kDa prostaglandin F2a analogue drug, Latanoprost, from commercially available contact lenses using in vitro models with corneal epithelial cells. Conventional polyHEMA-based and silicone hydrogel soft contact lenses were soaked in...
Guardado en:
Autores principales: | Saman Mohammadi, Lyndon Jones, Maud Gorbet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/113c582ef1694636a71f98596e53bc52 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In vitro release of two anti-muscarinic drugs from soft contact lenses
por: Hui A, et al.
Publicado: (2017) -
All-printed stretchable corneal sensor on soft contact lenses for noninvasive and painless ocular electrodiagnosis
por: Kyunghun Kim, et al.
Publicado: (2021) -
Use of therapeutic non-refractive contact lenses to improve visual outcome after repair of traumatic corneal wounds
por: Khater MM
Publicado: (2014) -
Use of a novel extended blink test to evaluate the performance of two polyvinylpyrrolidone-containing, silicone hydrogel contact lenses
por: Schafer J, et al.
Publicado: (2018) -
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye
por: Natarajan JV, et al.
Publicado: (2012)